KRAS and familial pancreatic carcinoma: Inspired by the application of exosomes in KRAS mutant pancreatic cancer treatment, Deng and colleagues constructed an exosome-mimicking membrane hybrid nanoplatform by fusing PEGylated lipids with the DC2.4 cell membrane for the benefits of easier generation and better loading efficiency 39.